{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:04:24Z","timestamp":1790175864496,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Cancer Center, Korea","award":["NCC-2310530, 2310500"],"award-info":[{"award-number":["NCC-2310530, 2310500"]}],"id":[{"id":"https:\/\/ror.org\/02tsanh21","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J of Prevention"],"DOI":"10.1007\/s10935-026-00945-3","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:15:08Z","timestamp":1790172908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Consecutive Negative Screening Tests for Ovarian Cancer: A Reliable Basis for Reassurance of Low Ovarian Cancer Mortality Risk?"],"prefix":"10.1007","author":[{"given":"Jieun","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kyung","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uisuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-9555","authenticated-orcid":false,"given":"Sokbom","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"issue":"3","key":"945_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/0003-4819-156-3-201202070-00006","volume":"156","author":"LM Baldwin","year":"2012","unstructured":"Baldwin, L. M., Trivers, K. F., Matthews, B., Andrilla, C. H., Miller, J. W., Berry, D. L., Lishner, D. M., & Goff, B. A. (2012). Vignette-based study of ovarian cancer screening: Do U.S. physicians report adhering to evidence-based recommendations? Annals of internal medicine, 156(3), 182\u2013194. https:\/\/doi.org\/10.7326\/0003-4819-156-3-201202070-00006","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"945_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029739","volume":"9","author":"B Bringedal","year":"2019","unstructured":"Bringedal, B., Fretheim, A., Nilsen, S., & Isaksson R\u00f8, K. (2019). Do you recommend cancer screening to your patients? A cross-sectional study of Norwegian doctors. BMJ Open, 9(8), Article e029739. https:\/\/doi.org\/10.1136\/bmjopen-2019-029739","journal-title":"BMJ Open"},{"issue":"22","key":"945_CR3","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1001\/jama.2011.766","volume":"305","author":"SS Buys","year":"2011","unstructured":"Buys, S. S., Partridge, E., Black, A., Johnson, C. C., Lamerato, L., Isaacs, C., Reding, D. J., Greenlee, R. T., Yokochi, L. A., Kessel, B., Crawford, E. D., Church, T. R., Andriole, G. L., Weissfeld, J. L., Fouad, M. N., Chia, D., O\u2019Brien, B., Ragard, L. R., Clapp, J. D., \u2026 PLCO Project Team. (2011). Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA, 305(22), 2295\u20132303. https:\/\/doi.org\/10.1001\/jama.2011.766","journal-title":"JAMA"},{"issue":"6","key":"945_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ypmed.2006.02.004","volume":"42","author":"JE Gaugler","year":"2006","unstructured":"Gaugler, J. E., Pavlik, E., Salsman, J. M., & Andrykowski, M. A. (2006). Psychological and behavioral impact of receipt of a normal ovarian cancer screening test. Preventive medicine, 42(6), 463\u2013470. https:\/\/doi.org\/10.1016\/j.ypmed.2006.02.004","journal-title":"Preventive medicine"},{"key":"945_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.21421","volume-title":"Screening for ovarian cancer: An updated evidence review for the U.S. Preventive services task force","author":"JT Henderson","year":"2018","unstructured":"Henderson, J. T., Webber, E. M., & Sawaya, G. F. (2018). Screening for ovarian cancer: An updated evidence review for the U.S. Preventive services task force. Agency for Healthcare Research and Quality (US)."},{"issue":"1","key":"945_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa110","volume":"5","author":"C Macdonald","year":"2020","unstructured":"Macdonald, C., Mazza, D., Hickey, M., Hunter, M., Keogh, L. A., Investigators, K., Jones, S. C., Saunders, C., Nesci, S., Milne, R. L., McLachlan, S. A., Hopper, J. L., Friedlander, M. L., Emery, J., & Phillips, K. A. (2020). Motivators of inappropriate ovarian cancer screening: A survey of women and their clinicians. JNCI Cancer Spectrum, 5(1), Article pkaa110. https:\/\/doi.org\/10.1093\/jncics\/pkaa110","journal-title":"JNCI Cancer Spectrum"},{"issue":"10290","key":"945_CR7","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","volume":"397","author":"U Menon","year":"2021","unstructured":"Menon, U., Gentry-Maharaj, A., Burnell, M., Singh, N., Ryan, A., Karpinskyj, C., Carlino, G., Taylor, J., Massingham, S. K., Raikou, M., Kalsi, J. K., Woolas, R., Manchanda, R., Arora, R., Casey, L., Dawnay, A., Dobbs, S., Leeson, S., Mould, T., Seif, M. W., & Parmar, M. (2021). Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial. Lancet (London England), 397(10290), 2182\u20132193. https:\/\/doi.org\/10.1016\/S0140-6736(21)00731-5","journal-title":"Lancet (London England)"},{"key":"945_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S197604","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed, Z., Tiznobaik, A., Taheri, S., & Salehiniya, H. (2019). Ovarian cancer in the world: Epidemiology and risk factors. International journal of women\u2019s health, 11, 287\u2013299. https:\/\/doi.org\/10.2147\/IJWH.S197604","journal-title":"International Journal of Women\u2019s Health"},{"issue":"6","key":"945_CR9","doi-asserted-by":"publisher","first-page":"273S","DOI":"10.1016\/s0197-2456(00)00098-2","volume":"21","author":"PC Prorok","year":"2000","unstructured":"Prorok, P. C., Andriole, G. L., Bresalier, R. S., Buys, S. S., Chia, D., Crawford, E. D., Fogel, R., Gelmann, E. P., Gilbert, F., Hasson, M. A., Hayes, R. B., Johnson, C. C., Mandel, J. S., Oberman, A., O\u2019Brien, B., Oken, M. M., Rafla, S., Reding, D., Rutt, W., \u2026 Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. (2000). Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Controlled Clinical Trials, 21(6), 273S-309S. https:\/\/doi.org\/10.1016\/s0197-2456(00)00098-2","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"945_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ygyno.2013.06.029","volume":"130","author":"CJ Reade","year":"2013","unstructured":"Reade, C. J., Riva, J. J., Busse, J. W., Goldsmith, C. H., & Elit, L. (2013). Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis. Gynecologic Oncology, 130(3), 674\u2013681. https:\/\/doi.org\/10.1016\/j.ygyno.2013.06.029","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"945_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ygyno.2016.11.047","volume":"144","author":"JL Ruberg","year":"2017","unstructured":"Ruberg, J. L., Helm, C. W., Felleman, B. I., Helm, J. E., & Studts, J. L. (2017). Is attendance at an ovarian cancer screening clinic a worry-reducing event? Findings from pre- to post-screening. Gynecologic Oncology, 144(2), 363\u2013368. https:\/\/doi.org\/10.1016\/j.ygyno.2016.11.047","journal-title":"Gynecologic Oncology"},{"issue":"3\u20134","key":"945_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/10937400701876095","volume":"11","author":"F Salehi","year":"2008","unstructured":"Salehi, F., Dunfield, L., Phillips, K. P., Krewski, D., & Vanderhyden, B. C. (2008). Risk factors for ovarian cancer: An overview with emphasis on hormonal factors. Journal of Toxicology and Environmental Health. Part B, Critical Reviews, 11(3\u20134), 301\u2013321. https:\/\/doi.org\/10.1080\/10937400701876095","journal-title":"Journal of Toxicology and Environmental Health. Part B, Critical Reviews"},{"issue":"4","key":"945_CR13","doi-asserted-by":"publisher","first-page":"CD001431","DOI":"10.1002\/14651858.CD001431.pub5","volume":"4","author":"D Stacey","year":"2017","unstructured":"Stacey, D., L\u00e9gar\u00e9, F., Lewis, K., Barry, M. J., Bennett, C. L., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Thomson, R., & Trevena, L. (2017). Decision aids for people facing health treatment or screening decisions. The Cochrane database of systematic reviews, 4(4), CD001431. https:\/\/doi.org\/10.1002\/14651858.CD001431.pub5","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"1","key":"945_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1090198111407185","volume":"39","author":"SL Stewart","year":"2012","unstructured":"Stewart, S. L., Rim, S. H., & Gelb, C. A. (2012). Physician knowledge and awareness of CA-125 as a screen for ovarian cancer in the asymptomatic, average-risk population. Health Education & Behavior: The Official Publication of the Society for Public Health Education, 39(1), 57\u201366. https:\/\/doi.org\/10.1177\/1090198111407185","journal-title":"Health Education & Behavior: The Official Publication of the Society for Public Health Education"},{"issue":"6","key":"945_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jama.2017.21926","volume":"319","author":"DC Grossman","year":"2018","unstructured":"US Preventive Services Task Force, Grossman, D. C., Curry, S. J., Owens, D. K., Barry, M. J., Davidson, K. W., Doubeni, C. A., Epling, J. W., Jr., Kemper, A. R., Krist, A. H., Kurth, A. E., Landefeld, C. S., Mangione, C. M., Phipps, M. G., Silverstein, M., Simon, M. A., & Tseng, C. W. (2018). Screening for ovarian cancer: US preventive services task force recommendation statement. JAMA, 319(6), 588\u2013594. https:\/\/doi.org\/10.1001\/jama.2017.21926","journal-title":"JAMA"},{"issue":"5","key":"945_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb, P. M., & Jordan, S. J. (2024). Global epidemiology of epithelial ovarian cancer. Nature reviews. Clinical Oncology, 21(5), 389\u2013400. https:\/\/doi.org\/10.1038\/s41571-024-00881-3","journal-title":"Clinical Oncology"},{"issue":"1","key":"945_CR17","doi-asserted-by":"publisher","first-page":"17181","DOI":"10.1038\/s41598-018-35585","volume":"8","author":"O Wegwarth","year":"2018","unstructured":"Wegwarth, O., & Gigerenzer, G. (2018). US gynecologists\u2019 estimates and beliefs regarding ovarian cancer screening\u2019s effectiveness 5 years after release of the PLCO evidence. Scientific reports, 8(1), 17181. https:\/\/doi.org\/10.1038\/s41598-018-35585-","journal-title":"Scientific Reports"},{"issue":"1","key":"945_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13861-y","volume":"22","author":"S Zhang","year":"2022","unstructured":"Zhang, S., Cheng, C., Lin, Z., Xiao, L., Su, X., Zheng, L., Mu, Y., Liao, M., Ouyang, R., Li, W., Ma, J., Cai, J., Liu, L., Wang, D., Zeng, F., & Liu, J. (2022). The global burden and associated factors of ovarian cancer in 1990\u20132019: Findings from the Global Burden of Disease Study 2019. BMC Public Health, 22(1), Article 1455. https:\/\/doi.org\/10.1186\/s12889-022-13861-y","journal-title":"BMC Public Health"}],"container-title":["Journal of Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10935-026-00945-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10935-026-00945-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10935-026-00945-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:15:10Z","timestamp":1790172910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10935-026-00945-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":18,"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1007\/s10935-026-00945-3","relation":{},"ISSN":["2731-5533","2731-5541"],"issn-type":[{"value":"2731-5533","type":"print"},{"value":"2731-5541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Cnflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki and ethical approval was waived by the Institutional Review Board of the National Cancer Center (No. NCC2023-0168).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants at the time of original data collection. The current study used retrospectively collected data under the approval of the institutional review board.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}